MedPath

Black seed vs. Tretinoin in acne vulgaris

Phase 2
Conditions
Acne vulgaris.
Acne vulgaris
L70.0
Registration Number
IRCT20191021045173N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Age between 18-50 years
Clinical diagnosis of mild to moderate facial acne (GAGS score ranging from 1 to 30) made by a dermatologist
Discontinuation of any topical or systemic treatment for acne from at least 3 months prior to participation

Exclusion Criteria

Pregnancy or lactation,
Women with hirsutism, menstrual disorders and hormonal problems,
Severe grade of acne,
Candidate for isotretinoin treatment,
Known allergy to black seed or tretinoin,
Subjects who are non-cooperative or unsatisfied with the treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath